Kishimoto Takashi Kei has filed 10 insider transactions across 1 company since January 2023.
Most recent transaction: a gift of 43000 shares of Cartesian Therapeutics, Inc. ($RNAC) on May 30, 2023.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 43000 | $0.00 | 321,316.0000 | 5,101,459 | 11.80% | 0.84% |
| May 30, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 43000 | $0.00 | 278,316.0000 | 5,101,459 | 13.38% | 0.84% |
| May 31, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 26500 | $0.00 | 251,816.0000 | 5,101,459 | 9.52% | 0.52% |
| May 31, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | G | Common Stock | 26500 | $0.00 | 225,316.0000 | 5,101,459 | 10.52% | 0.52% |
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 6381 | $1.13 | 367,719.0000 | 5,101,459 | 1.71% | 0.13% |
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 11 | $1.15 | 367,708.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 3372 | $1.13 | 364,336.0000 | 5,101,459 | 0.92% | 0.07% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | S | Common Stock | 20 | $1.11 | 364,316.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | A | Common Stock | 100000 | $0.00 | 374,100.0000 | 5,101,459 | 36.48% | 1.96% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kishimoto Takashi Kei | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 5,101,459 | 9999.99% | 9.31% |